Neurocycle Therapeutics
Neurocycle Therapeutics is a biopharmaceutical company that focuses on sub-type selective GABA-A modulation.
Neurocycle Therapeutics operates in biotechnology based in Greater Boston Area, East Coast, New England, Northeastern US, founded in 2016.
The company sits in the biotechnology segment, where it competes on its core product or service.
The company is recorded as being based in Greater Boston Area, East Coast, New England, Northeastern US.
It is recorded at the Grant stage.
The company reports a headcount in the c_00001_00010 range.
Public records show total funding of about $1K.
| Sector | Biotechnology |
|---|---|
| Headquarters | Greater Boston Area, East Coast, New England, Northeastern US |
| Founded | 2016 |
| Employees | c_00001_00010 |
| Stage | grant |
| Total funding | $10,000 |
Website: www.neurocycletherapeutics.com
Browse related
Sign in to view the contact information we hold for Neurocycle Therapeutics.
Create a free account
Create a free account